Chat with us, powered by LiveChat
BUY TICKETS

SAVE $901 BY JAN. 15

 Speaker Profile

M.D., Partner, Genesis Biocapital

Biography
Jay G. Wohlgemuth, MDPartner, Genesis BioCapital, CEO, PacegenixDr. Jay Wohlgemuth has years of experience leading diagnosticpharmaceutical programs. He served as CMO, SVP for Quest for over a dozen years where he was responsible for RD, Medical, Quests RD and Medical COVID responses, Quests Employer business and healthplan for which he received a Koop Award for the best population health program in the US in 2020. He served as CMO of HealthTap, and as the development team leader for Ocrevus and director of diagnostics for programs for Genentech. He was co-founder and CMO of CareDx, for which he was awarded Technology Pioneer 2005 at the World Economic Forum in Davos. He also served as chairman of the board for the Personalized Medicine Coalition.Dr. Wohlgemuth earned his BA at Harvard and his MD and cardiology training at Stanford. He is Trustee of the The Anne and Henry Zarrow Foundation.


Talk
Enabling Breakthrough Therapeutics: Data, Diagnostics and Newco Formation
TBD


Clinical Dx Showcase:
Genesis Biocapital

Genesis Biocapital is a venture firm focused on company creation around breakthrough therapeutics enabled by data and diagnostics. Pacegenix is a Genesis Biocapital portfolio company focused on enabling precision medicine in the area of cardiac rhythm disorders.

 Session Abstract – PMWC 2026 Silicon Valley

Showcase Track S2 - March 4 11.00 A.M.-5.00 P.M.,Showcase Track S2 - March 5 9.15 A.M.-12.00 P.M.,Showcase Track S1 - March 6 11.30 A.M.-11.45 A.M.


The PMWC 2026 Data Applications in Clinical Diagnostics Showcase will provide a 15-30 minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.

  • Clinical Dx/Oncology (including Liquid Biopsy)
  • Clinical Dx/Cardio Vascular
  • Clinical Dx/Neurodegenerative

×

Add Names/PO on Receipt

Apply to Speak at PMWC Silicon Valley by JAN. 15TH

The PMWC team will reply back to a suitable company/topic with an official request for talk/speaker details.

Contact Us:

Fields marked with an * are required 

Discover What's Next in Precision Medicine!

Join our community today for the latest news, exclusive interviews, and unique insights from world-renowned speakers and experts


Request Atul Butte Company Competition Submission Form

Fields marked with an * are required

Contact Us:

Fields marked with an * are required 

Trouble Registering

Fields marked with an * are required

Stay Tuned For More Information.

Sign up for occasional updates on upcoming conferences, news, and other information. 

Get Updates:

Submit to Speak in the PMWC Showcase

Fields marked with an * are required